Cells and cytokines involved in the pathogenesis of sarcoidosis

Sarcoidosis Vasculitis and Diffuse Lung Disease

Volumn 16, Issue 1, 1999, Pages 24-31

  Moller, David R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Granuloma formation; Interleukin 10; Interleukin 12; Pentoxifylline; Sarcoidosis; TGF ; Th1 cells

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; TRANSFORMING GROWTH FACTOR BETA;

CYSTIC FIBROSIS; DENDRITIC CELL; FIBROBLAST; GRANULOMATOUS INFLAMMATION; HUMAN; IMMUNE RESPONSE; LUNG; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; LYMPH NODE; MONONUCLEAR PHAGOCYTE; PATHOGENESIS; PRIORITY JOURNAL; REMISSION; REVIEW; SARCOIDOSIS; T LYMPHOCYTE;

CYTOKINES; FIBROSIS; GRANULOMA; HUMANS; INFLAMMATION; LUNG DISEASES; MACROPHAGES; MODELS, THEORETICAL; SARCOIDOSIS; T-LYMPHOCYTES; TH1 CELLS;

EID: 0032939961     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Mitchell DN, Scadding JG: Sarcoidosis 1974; 110: 774-801.
2. Sher A, Coffman RL: Regulation of immunity 10 parasites by T cells and T cell-derived cytokines. Ann Rev Immunol 1992; 10: 385.
3. Davis NM, Bjorkman PJ: T-cell antigen receptor genes and T-cell recognition. Nature 1988; 334: 395-102.
4. Hedrick SM, Engle I, McElliott DL et al: Selection of amino acid sequences in the beta chain of the T cell antigen receptor. Science 1988; 239: 1541-1544.
5. Moller DR: T-cell receptor genes in Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1998; 15: 158-164.
6. Moller DR, Konishi K, Kirby M et al: Bias toward use of a specific T cell receptor β-chain variable region in a subgroup of individuals with sarcoidosis. J Clin Invest 1988; 82: 1183-1191.
7. Grunewald J, Janson CH, Eklund A et al: Restricted Va2.3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3. Eur J Immunol 1992; 22: 129-135.
8. Klein JT, Horn D, Forman JD et al: Selection of oligoclonal Vβ-specific T-cells in the intradermal response to Kveim-Siltzbach reagent in individuals with sarcoidosis. J Immunol 1994; 154: 1450-1458.
9. Forman JD, Klein JT, Silver RF et al: Selective activation and accumulation of oligoclonal Vβ-specific T-cells in active pulmonary sarcoidosis. J Clin Invest 1994; 94: 1533-1542.
10. Bellocq A, Lecossier D, Pierre-Audigier C et al: T-Cell receptor repertoire of T lymphocytes recovered from the lung and blood of patients with sarcoidosis. Am J Respir Crit Care Med 1994; 149: 646-654.
11. Forrester JM, Wang Y, Ricalton N et al: TCR expression of activated T cell clones in the lungs of patients with pulmonary sarcoidosis. J Immunol 1994; 153: 4291-4302.
12. Dohi M, Yamamoto K, Masuko K et al: Accumulation of multiple T cell clonotypes in lungs of healthy individuals and patients with pulmonary sarcoidosis. J Immunol 1994; 152: 1983-1988.
13. Grunewald J, Hultman T, Bucht A et al: Restricted usage of T cell receptor V alpha/J alpha gene segments with different nucleotide but identical amino acid sequences in HLA-DR3+ sarcoidosis patients. Mol Med 1995; 1(3): 287-296.
14. Usui Y, Kohsaka H, Eishi Y et al: Shared amino acid motifs in T-cell receptor β junctional regions of bronchoalveolar T cells in patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1996; 154; 50-56.
15. Silver RF, Crystal RG, Moller DR: Limited heterogeneity of biased T-cell receptor Vβ gene usage in lung but not blood T cells in active pulmonary sarcoidosis. Immunology 1996; 88: 516-523.
16. Jones CM, Lake RA, Wijeyekoon JB et al: Oligoclonal V gene usage by T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients. Am J Respir Cell Mol Biol 1996; 14: 470-477.
17. Mossman TR and Coffman RL: Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989; 7: 145-173.
18. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM: Reciprocal expression of interferon-γ or IL-4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 1989; 169: 59.
19. Trinchieri G, Gerosa F: Immunoregulation by interleukin-12. J Leuk Biol 1996; 59: 505-511.
20. Mossman TR, Moore KW: The role of IL10 in cross-regulation of Th1 and Th2 responses. Immunol Today 1991; 12: A49-A53.
21. Pelz G: A role of CD4+ T-cell subsets producing a selective pattern of lymphokines in the pathogenesis of human chronic inflammatory and allergic diseases. Immunol Rev 1991; 123: 23.
22. Locksley RM: Interleukin 12 in host defense against microbial pathogens. Proc Natl Acad Sci USA 1993; 90: 5879.
23. Wynn TA, Eltoum I, Cheever AW, Lewis FA, Gause WC, Sher A: Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J Immunol 1993; 151: 1430-1440.
24. Chensue SW, Warmington K, Ruth J, Lincoln P, Kuo M-C, Kunkel SL: Cytokine responses during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. Production of Th1 and Th2 cytokines and relative contribution of tumor necrosis factor. Am J Pathol 1994; 145: 1105-1113.
25. Robinson BWS, McLemore TL, Crystal RG: Gamma interferon is spontaneously released by alveolar macrophages and lung T-lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest 1985; 75: 1488.
26. Pinkston P, Bitterman PB, Crystal RG: Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med 1983; 308: 793-800.
27. Müller-Quernheim JC, Saltini C, Sondermeyer P, Crystal RG: Compartmentalized activation of the interleukin 2 gene by lung T lymphocytes in active pulmonary sarcoidosis. J Immunol 1986; 137: 3475.
28. Saltini C, Spurzem JR, Lee JJ, Pinkston P, Crystal RG: Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the LEU3+ DR+ T cell subset. J Clin Invest 1986; 77: 1962.
29. Walker C, Bauer W, Braun RK et al: Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 1994; 150: 1038.
30. Moller DR, Forman JD, Liu MC et al: Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 1996; 145: 4952-4960.
31. Horton MR, McKee CM, Farber J et al: Hyaluronan fragments synergize with IFN-γ to induce the C-X-C chemokine MIG in mouse macrophages and alveolar macrophages from patients with sarcoidosis. Am J Resp Crit Care Med 1997; 155: A501.
32. Bergeron A, Bonay M, Kambouchner M et al: Cytokine patterns in tuberculosis and sarcoid granulomas: Correlations with histopathologic features of the granulomatous response. J Immunol 1997; 159: 3034-3043.
33. Baumer I, Zissel G, Schlack M, Müller-Quernheim J: Th1/Th2 cell distribution in pulmonary sarcoidosis. Am J Respir Cell Molec Biol 1997; 16: 171-177.
34. Krouwels FH, Necher RET, Snoek M et al: Immunocytochemical and flow-cytometric detection of intracellular IL-4, IL-5 and IFN-γ: applications using blood-and airway-derived cells. J Immunol Methods 1997; 203: 89-101.
35. Zissel G, Homolka J, Schlaak J, Schlaak M, Müller-Quernheim J: Anti-inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis. Am J Respir Crit Care Med 1996; 154: 713-719.
36. Trembleau S, Germann T, Gately MK, Adorini L: The role of IL12 in the induction of organ-specific autoimmune diseases. Immunol Today 1995; 16: 363.
37. Seder RA, Kelsall BL, Jankovic D: Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. J Immunol 1996; I 157: 2745-2748.
38. Segal BM, Klinman DM, Shevach EM: Microbial products induce autoimmune disease by an IL-12 dependent pathway. J Immunol 1997; 158: 5087-5090.
39. Bachwich PR, Lynch JP, Larrick J et al. Tumour necrosis factor production by human sarcoid alveolar macrophages. Am J Pathol 1986; 125: 421.
40. Spatofora M, Merendino A, Chiappara G et al: Lung compartmentalization of increased TNF releasing ability by mononuclear phagocytes in pulmonary sarcoidosis. Chest 1989; 96: 542.
41. Hunninghake GW: Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis. Ann Rev Respir Dis 1984; 129: 569.
42. Wewers MD, Saltini C, Sellers S et al: Evaluation of alveolar macrophages in normals and individuals with active pulmonary sarcoidosis for the spontaneous expression of the interleukin-1β gene. Cell Immunol 1937; 107: 479.
43. Melis M, Gjomarkaj M, Pace E et al: Increased expression of leukocyte function associated antigen-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1) by alveolar macrophages of patients with pulmonary sarcoidosis. Chest 1991; 100: 910.
44. Spurzem JR, Saltini C, Kirby M et al: Expression of HLA class II genes in alveolar macrophages of patients with sarcoidosis. Am Rev Resptr Dis 1989; 140: 89.
45. Lern VM, Lipscomb MF, Weissler JC et al: Bronchoalveolar cells from sarcoid patients demonstrate enhanced antigen presentation. J Immunol 1985; 135: 1766-1771.
46. Wahl SM, McCartney-Francis N, and Mergenhagen S. Inflammatory and immunoregulatory roles of TGFβ. Immunol Today 1989; 10: 258-261.
47. Kehrl JH, Wakefield LM, Roberts AB et al: Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986; 163: 1037-1050.
48. Limper AH, Colby TV, Sanders MS, Asakura S, Roche PC, DeRemee RA: Immunohistochemical localization of transforming growth factor-β, in the nonnecrotizing granulomas of pulmonary sarcoidosis. Am J Respir Crit Care Med, 1994; 149: 197-204.
49. Schmitt E, Hohn C, Huls C et al: T helper type 1 development of naïve CD4+ T cells requires the coordinated action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur J Immunol 1994; 24: 793-798.
50. D'Andrea AM, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G: Interleukin 10(IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993; 178: 1041.
51. D'Andrea AM, Ma X, Aste-Amezage M, Paganin C, Trinchieri G: Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor α production. J Exp Med 1995; 181: 537.
52. van der Pouwkraan TC, Boeije LC, Sweenk RJ, Wijdenes J, Aarden LA: Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 1995; 181: 775-779.
53. Wynn TA, Cheever AW, Jankovic D et al: An IL-12-based vaccination method for preventing fibrosis induced by schislosome infection. Nature 1995; 376: 594-596.
54. Lukacs NW, Addison CL, Gauldie J et al: Transgene-induced production of IL-4 alters the development and collagen expression of T helper cell 1-type pulmonary granulomas. J Immunol 1997; 158: 4478-4484.
55. Fertin C, Nicolac JF, Gillery P, Kalis B, Baucherau J, Maguart FX: Interleukin-4 stimulate collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents. Cell Mol Biol 1991; 37: 823.
56. Orne IM, Roberts AD, Griffin JP, Abrams JS: Cytokine secretion of CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol 1993; 151: 1-6.
57. Zabel P, Entzian P, Dalhoff K, Schlaak M: Pentoxifylline in treatment of sarcoidosis. Am J Respir Crit Care Med 1997; 155: 1665-1669.
58. Moller DR, Wysocka M, Greenlee B et al: Inhibition of human interleukin-12 production by pentoxifylline. Immunology 1997; 91: 197-203.
59. Moller DR, Wysocka M, Greenlee BM et al: Inhibition of interleukin-12 production by thalidomide. J Immunol 1997; 159: 5157-5161.